7 alpha-hydroxy-4-cholesten-3-one and Overweight

7 alpha-hydroxy-4-cholesten-3-one has been researched along with Overweight in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bliss, C; Jennings, L; Martin, P; Palmer, M; Silberg, DG	1

Trials

1 trial(s) available for 7 alpha-hydroxy-4-cholesten-3-one and Overweight

Article	Year
A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis. BMC pharmacology & toxicology, 2018, 03-16, Volume: 19, Issue:1 Topics: Adult; Benzothiepins; Bile Acids and Salts; Cholestenones; Double-Blind Method; Feces; Female; Glycosides; Healthy Volunteers; Humans; Lipid Regulating Agents; Lipids; Male; Middle Aged; Overweight	2018

Article

Year

A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitis.

BMC pharmacology & toxicology, 2018, 03-16, Volume: 19, Issue:1

Topics: Adult; Benzothiepins; Bile Acids and Salts; Cholestenones; Double-Blind Method; Feces; Female; Glycosides; Healthy Volunteers; Humans; Lipid Regulating Agents; Lipids; Male; Middle Aged; Overweight

2018